Cosmeceuticals and active ingredients.
Cosmetic ingredients previously considered "inert" have potential to provide a biologic effect to skin. In a cosmeceutical formulation, the boundary between an "active" and "inert" ingredient may be obscured. For this reason, the cosmeceutical distributor must find a nonambiguous method to demonstrate the efficacy of a new ingredient. For a product to be successful in the marketplace, the benefits of the product must clearly be communicated to the consumer, and the consumer must be satisfied with product performance.
Lintner
Karl
K
Sederma S.A.S., F-78612 Le Perray en Yvelines, BP 33, 29 rue du Chemin Vert, Cedex, France. karl.lintner@sederma.fr
Mas-Chamberlin
Claire
C
Mondon
Philippe
P
Peschard
Olivier
O
Lamy
Louis
L
D000279:Administration, Cutaneous; D003257:Consumer Product Safety; D003358:Cosmetics / Q000494:pharmacology* / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004339:Drug Compounding; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D008297:Male; D012869:Skin Absorption / Q000187:drug effects*; D015595:Skin Aging / Q000187:drug effects; D017592:Skin Care / Q000379:methods; D012995:Solubility; D013501:Surface-Active Agents
D003358:Cosmetics; D003879:Dermatologic Agents; D013501:Surface-Active Agents